Skip to content
DraconiticResearch
Search Sources API
186,086 studies31 sourcesUpdated 12 min ago
Peer-reviewedCC BYFrontiers in medicine

Early applications of apple vision pro in clinical medicine and medical education: a scoping review

4 affiliations
  1. 1Department of Thoracic Surgery, The First Affiliated Hospital with Nanjing Medical University , ,
  2. 2Department of Thoracic Surgery, Huai’an Second People's Hospital, The Affiliated Huai’an Hospital of Xuzhou Medical University , ,
  3. 3Department of Pain Management, Huai’an Second People's Hospital, The Affiliated Huai’an Hospital of Xuzhou Medical University , ,
  4. 4The First School of Clinical Medicine, Nanjing Medical University , ,

Abstract

The Apple Vision Pro (AVP), a next-generation spatial computing device, has demonstrated potential applications in multidisciplinary clinical diagnosis, treatment, and medical education, by leveraging its unique technical architecture and performance advantages. In clinical practice, its fundamental advantages of three-dimensional (3D) visualization, real-time image integration, and immersive interaction have been preliminarily employed in disease diagnosis and treatment, surgical planning, precise operations, and postoperative rehabilitation across multiple disciplines. In medical education, AVP surpasses the limitations of conventional models, offering a novel methodology for anatomy education, clinical skills development, specialized practical training, and collaboration of distance learning, thereby alleviating persistent challenges such as unequal distribution of teaching resources, low efficiency in skills and specialized training, and the high cost of distance education. However, AVP faces some limitations, including limited hardware portability, insufficient system compatibility, a lack of specialized medical applications, high costs, and incomplete medical certification. Currently, most evidence derives from feasibility studies, case reports, and opinion pieces. Only two Stage 2b confirmatory studies were identified. Thus, high-level evidence for clinical benefit remains scarce. Readers should interpret all reported benefits as preliminary technical demonstrations rather than established clinical outcomes. Future advancements necessitate iterative development of lightweight hardware design, development of specialized medical software, cross-system optimization, and establishment of standardization protocols. Moreover, more randomized controlled trials (RCTs) and multicenter studies are urgently needed to fully explore and validate its intrinsic value in precision medicine and the equitable allocation of medical resources.

Related

  1. Retrieval-augmented generation in medicine: A scoping review of technical implementations, clinical applications, and ethical considerations
    Rui Yang, Matthew Yu Heng Wong, Huitao Li +13
    Cell Reports MedicinePeer-reviewedCC BY-NC-ND12 citedEpidemiology & public healthOpenAlex
  2. Educational Interventions for Professional Identity Formation in Undergraduate Medical Education: A Scoping Review
    Dinesh Kumar Narayanasamy, Divyashanthi Chellathambi Malathi, Nilakantan Ananthakrishnan
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Chemistry-medicine interdisciplinary integration in medical education: a narrative review of teaching reform, evidence synthesis, and international perspectives.
    Abliz Abdurahman, Xiaoli Ma, Yu Zhang +1
    Frontiers in medicinePeer-reviewedCC BYFull textEpidemiology & public healthEurope PMC
  4. What the AI era doctor should know: a scoping review of proposed artificial intelligence competencies for medical education
    Victor M. Hunt, Laurine Kristin Sprehe, Weston C de Lomba +8
    npj Digital MedicinePeer-reviewedCC BYFull text13 citedEpidemiology & public healthOpenAlex
  5. Telemedicine education for medical students and residents worldwide: A scoping review protocol
    Joshua Vo, Tina Mai, Nhi Yen Bui +3
    PLOS OnePeer-reviewedCC BY 4.0Full textNeuroscienceClinical trials & evidence synthesisPLOS
BibTeX
@article{hu2026early,
  title = {{Early applications of apple vision pro in clinical medicine and medical education: a scoping review}},
  author = {Yiwei Hu and Yaqin Wang and Xiaohua Zuo and Haibo Hu and Bo Min and Chengxiang Wang and Zilong Tang and Ning Xiao and Chenjun Huang and Chuxu Wang},
  journal = {Frontiers in medicine},
  year = {2026},
  month = oct,
  doi = {10.3389/fmed.2026.1909038},
  url = {https://europepmc.org/article/PMC/PMC13721002},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Early applications of apple vision pro in clinical medicine and medical education: a scoping review
AU  - Yiwei Hu
AU  - Yaqin Wang
AU  - Xiaohua Zuo
AU  - Haibo Hu
AU  - Bo Min
AU  - Chengxiang Wang
AU  - Zilong Tang
AU  - Ning Xiao
AU  - Chenjun Huang
AU  - Chuxu Wang
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2026.1909038
UR  - https://europepmc.org/article/PMC/PMC13721002
AB  - The Apple Vision Pro (AVP), a next-generation spatial computing device, has demonstrated potential applications in multidisciplinary clinical diagnosis, treatment, and medical education, by leveraging its unique technical architecture and performance advantages. In clinical practice, its fundamental advantages of three-dimensional (3D) visualization, real-time image integration, and immersive interaction have been preliminarily employed in disease diagnosis and treatment, surgical planning, precise operations, and postoperative rehabilitation across multiple disciplines. In medical education, AVP surpasses the limitations of conventional models, offering a novel methodology for anatomy education, clinical skills development, specialized practical training, and collaboration of distance learning, thereby alleviating persistent challenges such as unequal distribution of teaching resources, low efficiency in skills and specialized training, and the high cost of distance education. However, AVP faces some limitations, including limited hardware portability, insufficient system compatibility, a lack of specialized medical applications, high costs, and incomplete medical certification. Currently, most evidence derives from feasibility studies, case reports, and opinion pieces. Only two Stage 2b confirmatory studies were identified. Thus, high-level evidence for clinical benefit remains scarce. Readers should interpret all reported benefits as preliminary technical demonstrations rather than established clinical outcomes. Future advancements necessitate iterative development of lightweight hardware design, development of specialized medical software, cross-system optimization, and establishment of standardization protocols. Moreover, more randomized controlled trials (RCTs) and multicenter studies are urgently needed to fully explore and validate its intrinsic value in precision medicine and the equitable allocation of medical resources.
SN  - 2296-858X
ER  -